source Post navigation Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus – PR Newswire Probability of cardiovascular events lower in type 1 diabetes versus type 2 – McKnight's Senior Living